Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria de Navarra (40)

2024

  1. Anti-Obesity Effects of a Collagen with Low Digestibility and High Swelling Capacity: A Human Randomized Control Trial

    Nutrients , Vol. 16, Núm. 20

  2. Application of Gut Bacterial Profiling Information in Precision Nutrition for Obesity and Weight Loss Management

    Lifestyle genomics, Vol. 17, Núm. 1, pp. 22-30

  3. Changes in faecal microbiota in 6- to 12-year-old children after a new nutritional strategy: the ALINFA randomised controlled trial

    International Journal of Food Science and Technology

  4. Inflammatory markers as diagnostic and precision nutrition tools for metabolic dysfunction-associated steatotic liver disease: Results from the Fatty Liver in Obesity trial

    Clinical Nutrition, Vol. 43, Núm. 7, pp. 1770-1781

  5. MicroRNAs from edible plants reach the human gastrointestinal tract and may act as potential regulators of gene expression

    Journal of Physiology and Biochemistry

  6. Plant miR6262 Modulates the Expression of Metabolic and Thermogenic Genes in Human Hepatocytes and Adipocytes

    Nutrients , Vol. 16, Núm. 18

  7. Plant miR8126-3p and miR8126-5p Decrease Lipid Accumulation through Modulation of Metabolic Genes in a Human Hepatocyte Model That Mimics Steatosis

    International Journal of Molecular Sciences, Vol. 25, Núm. 3

2023

  1. A Predictive Tool Based on DNA Methylation Data for Personalized Weight Loss through Different Dietary Strategies: A Pilot Study

    Nutrients, Vol. 15, Núm. 24

  2. Crosstalk between Gut Microbiota and Epigenetic Markers in Obesity Development: Relationship between Ruminococcus, BMI, and MACROD2/SEL1L2 Methylation

    Nutrients, Vol. 15, Núm. 7

  3. Isoliquiritigenin in combination with visceral adipose tissue and related markers as a predictive tool for nonalcoholic fatty liver disease

    Journal of Physiology and Biochemistry

  4. Nutritional Interventions with Bacillus coagulans Improved Glucose Metabolism and Hyperinsulinemia in Mice with Acute Intermittent Porphyria

    International Journal of Molecular Sciences, Vol. 24, Núm. 15

  5. Pediococcus acidilactici (pA1c®) alleviates obesity-related dyslipidemia and inflammation in Wistar rats by activating beta-oxidation and modulating the gut microbiota

    Food and Function, Vol. 14, Núm. 24, pp. 10855-10867

  6. Pediococcus acidilactici pA1c® Improves the Beneficial Effects of Metformin Treatment in Type 2 Diabetes by Controlling Glycaemia and Modulating Intestinal Microbiota

    Pharmaceutics, Vol. 15, Núm. 4

2022

  1. A nutrigenetic tool for precision dietary management of non-alcoholic fatty liver disease deeming insulin resistance markers

    Panminerva medica, Vol. 64, Núm. 4, pp. 485-496

  2. A weight-loss model based on baseline microbiota and genetic scores for selection of dietary treatments in overweight and obese population

    Clinical Nutrition, Vol. 41, Núm. 8, pp. 1712-1723

  3. Association of the Gut Microbiota with the Host’s Health through an Analysis of Biochemical Markers, Dietary Estimation, and Microbial Composition

    Nutrients, Vol. 14, Núm. 23

  4. Differentially methylated regions (DMRs) in PON3 gene between responders and non-responders to a weight loss dietary intervention: a new tool for precision management of obesity

    Epigenetics, Vol. 17, Núm. 1, pp. 81-92

  5. Effects of gut microbiota–derived extracellular vesicles on obesity and diabetes and their potential modulation through diet

    Journal of Physiology and Biochemistry, Vol. 78, Núm. 2, pp. 485-499

  6. Genetic and epigenetic nutritional interactions influencing obesity risk and adiposity outcomes

    Current opinion in clinical nutrition and metabolic care, Vol. 25, Núm. 4, pp. 235-240

  7. Lactiplantibacillus plantarum DSM20174 Attenuates the Progression of Non-Alcoholic Fatty Liver Disease by Modulating Gut Microbiota, Improving Metabolic Risk Factors, and Attenuating Adipose Inflammation

    Nutrients, Vol. 14, Núm. 24